A Comprehensive Pharmacological and Clinical Review of Broccoli (Brassica oleracea): From Allergenic Extract to a Source of Bioactive Sulforaphane

Executive Summary

This report provides a comprehensive analysis of broccoli (Brassica oleracea) within a pharmacological and clinical context, navigating its dual identity as both a source for a regulated allergenic extract and a rich reservoir of therapeutically significant phytochemicals. The substance identified in DrugBank as DB10511 is a non-standardized allergenic extract used exclusively for the percutaneous, intradermal, or subcutaneous diagnosis of Type I hypersensitivity to broccoli. This application stands in stark contrast to the vast body of scientific research focused on the health benefits of broccoli consumption, which are attributed not to its allergenic proteins but to its unique phytochemical profile.

The primary bioactive potential of broccoli stems from the glucosinolate-myrosinase system. The plant contains high concentrations of glucoraphanin, a stable but biologically inert glucosinolate. Upon tissue damage, such as chewing or cutting, the enzyme myrosinase is released, hydrolyzing glucoraphanin into sulforaphane—a highly reactive and potent isothiocyanate. Sulforaphane is responsible for the majority of broccoli's observed health benefits, acting as a powerful indirect antioxidant and anti-inflammatory agent. Its principal mechanism of action is the potent activation of the Nrf2 transcriptional pathway, which upregulates a vast array of cytoprotective genes, including Phase II detoxification and antioxidant enzymes. Furthermore, sulforaphane exhibits pleiotropic anticancer activity through the induction of apoptosis, cell cycle arrest, and epigenetic modulation, including histone deacetylase (HDAC) inhibition.

Despite its pharmacodynamic potency, the clinical utility of sulforaphane is fundamentally limited by its highly variable pharmacokinetics. Bioavailability is the critical rate-limiting factor, determined primarily by the presence of active myrosinase at the time of consumption. Raw or lightly cooked broccoli, which retains enzyme activity, yields significantly higher systemic exposure to sulforaphane than heavily cooked preparations or supplements lacking myrosinase. This variability presents a major challenge in clinical research and helps explain the inconsistent outcomes observed across human trials.

Clinical evidence suggests sulforaphane is effective at modulating biomarkers associated with disease risk, such as enhancing the detoxification of airborne pollutants, improving liver function enzymes, reducing markers of inflammation (IL-6, C-reactive protein), and slowing the proliferation of certain cancer cells (Ki-67, PSA doubling time). However, its efficacy in treating established, advanced diseases is limited. Regulatory frameworks in the United States, Europe, and Australia classify broccoli-derived products as dietary supplements or herbal medicines, strictly limiting the health claims that can be made and creating a significant gap between the scientific evidence and what can be communicated to consumers. Future progress in this field depends on the development of formulations that ensure consistent bioavailability and the execution of large-scale, well-controlled clinical trials to validate the promising but preliminary findings to date.

Introduction: Deconstructing "Broccoli" in a Pharmacological Context

The term "broccoli" carries a dual meaning in the pharmacological landscape, representing two distinct entities with opposing biological effects. On one hand, it refers to a formally approved allergenic extract used for diagnostic purposes. On the other, it denotes the widely consumed vegetable, Brassica oleracea var. italica, which is a subject of intense scientific investigation for its health-promoting and disease-preventing phytochemicals. A clear delineation between these two identities is essential for a nuanced understanding of its role in medicine and nutrition.

The Approved Allergenic Extract (DrugBank ID: DB10511)

The substance officially cataloged in the DrugBank database under accession number DB10511 is a non-standardized food allergenic extract derived from broccoli.[1] Classified as a biotech drug and an allergen extract, its sole approved indication is for use in diagnostic allergy testing.[1] The purpose of this extract is to identify individuals with a Type I hypersensitivity (a classic allergy) to broccoli.

When administered via percutaneous (skin prick) or intradermal routes, the extract introduces broccoli proteins to the immune system of a potentially sensitized individual. In an allergic person, this provokes a localized immune response characterized by the degranulation of mast cells, leading to increased histamine release and the hallmarks of an allergic reaction.[1] This diagnostic tool operates by intentionally triggering a controlled, localized inflammatory cascade.

Several prescription products based on this extract have been approved for use in the United States, with some having been on the market for decades. These are typically formulated as injectable solutions for diagnostic administration. This formal classification as a "drug" is confined to this very specific diagnostic application, which is also true for extracts from related vegetables like cauliflower and turnip.[2]

Table 1: Approved Allergenic Extract Products (DB10511)

Name	Dosage Form	Strength	Route of Administration	Labeller	Marketing Start Date
Broccoli	Injection, solution	0.10 g/1mL	Percutaneous	ALK-Abello, Inc.	1998-02-23
Broccoli	Injection, solution	0.1 g/1mL	Intradermal; Subcutaneous	Nelco Laboratories, Inc.	1972-08-29
Broccoli	Solution	0.025 g/1mL	Intradermal; Percutaneous; Subcutaneous	Greer Laboratories, Inc.	1981-09-15
Broccoli	Injection, solution	0.05 g/1mL	Intradermal; Subcutaneous	Antigen Laboratories, Inc.	1974-03-23
Broccoli	Injection, solution	1 g/20mL	Percutaneous; Subcutaneous	Allergy Laboratories, Inc.	1972-08-29
(Data sourced from DrugBank) 1

The Botanical Source: Brassica oleracea var. italica and its Phytochemical Significance

Separate from its role as an allergen, the broccoli plant (Brassica oleracea var. italica) is a member of the cabbage family (Brassicaceae) and is consumed globally as a vegetable.[3] Originating in the Mediterranean region around the 6th century BC, it has long been valued for its nutritional content.[4] Broccoli is a source of vegetal protein, dietary fiber, vitamins, and minerals.[3]

The intense scientific interest in broccoli, however, is not due to its basic nutritional profile but to its rich content of unique phytochemicals. Extensive preclinical and clinical research has demonstrated that broccoli and its extracts possess potent anti-cancer, anti-inflammatory, antioxidant, antimicrobial, and neuroprotective properties.[3] These therapeutic activities are attributed to a class of sulfur-containing secondary metabolites known as glucosinolates and their bioactive hydrolysis products, principally isothiocyanates.[6] This positions the broccoli plant as a source of compounds that actively work to reduce inflammation and cellular damage, a function diametrically opposed to that of the allergenic extract used to induce an inflammatory response for diagnostic purposes. This report will henceforth focus on the pharmacology of these therapeutic phytochemicals derived from broccoli.

Core Bioactive Phytochemicals: The Glucosinolate-Myrosinase System

The therapeutic potential of broccoli is rooted in a unique biochemical system involving a stable precursor molecule and a highly reactive, bioactive metabolite. The conversion between these two states is catalyzed by an endogenous plant enzyme, a process often referred to as the "mustard oil bomb," which serves as a defense mechanism for the plant.[10] Understanding this precursor-product relationship is fundamental to appreciating the pharmacology and clinical challenges associated with broccoli-derived compounds.

Glucoraphanin: The Stable Glucosinolate Precursor

Glucosinolates (GSLs) are a class of sulfur- and nitrogen-containing secondary metabolites found almost exclusively in plants of the Brassica family.[9] The most prominent GSL in broccoli is glucoraphanin, also known by its chemical name 4-methylsulfinylbutyl glucosinolate.[8] In its intact form, glucoraphanin is a chemically stable, water-soluble molecule that is considered biologically inert or inactive.[15] Within the plant's cells, glucoraphanin is sequestered in vacuoles, keeping it physically separated from the enzyme that can activate it.[10]

Structurally, glucoraphanin (chemical formula $C_{12}H_{23}NO_{10}S_3$) shares the core structure of all glucosinolates: a $\beta$-D-thioglucose group, a sulphonated oxime moiety, and a variable side chain derived from an amino acid—in this case, methionine.[8] Its stability and water solubility make it an ideal compound for extraction and formulation into dietary supplements. However, its biological inactivity means that for it to exert any therapeutic effect, it must first be converted into its active form. In this capacity, glucoraphanin functions as a natural pro-drug.[15]

Sulforaphane: The Potent Isothiocyanate Metabolite

Sulforaphane (SFN) is the bioactive isothiocyanate (ITC) derived from glucoraphanin. Its chemical name is 1-Isothiocyanato-4-(methylsulfinyl)butane, and its formula is $C_6H_{11}NOS_2$.[8] SFN is not typically present in intact, undamaged broccoli. It is formed only when the plant's cells are ruptured—through cutting, chopping, or chewing—which allows glucoraphanin to come into contact with the myrosinase enzyme.[9] Myrosinase rapidly hydrolyzes the glucose moiety from glucoraphanin, creating an unstable intermediate that spontaneously rearranges to form SFN.[16]

In stark contrast to its stable precursor, SFN is a highly reactive, lipophilic, and biologically potent molecule.[15] This reactivity is the basis for its ability to interact with numerous cellular targets and exert powerful biological effects. However, this same reactivity also renders SFN relatively unstable, particularly in aqueous solutions and when exposed to heat, oxygen, or certain pH levels, making it a challenging compound to isolate and formulate into a stable product for direct consumption.[15] It is this potent but unstable molecule that is credited with the majority of broccoli's extensively researched health benefits, including its profound antioxidant, anti-inflammatory, and anticancer activities.[3] The inverse relationship between the stability of the precursor and the activity of the metabolite forms the central paradox of broccoli-based therapeutics, a challenge that directly influences formulation strategies and clinical outcomes.

Pharmacodynamics and Multi-Target Mechanisms of Action of Sulforaphane

Sulforaphane is not a conventional single-target agent but a pleiotropic molecule that exerts its wide-ranging biological effects by modulating a small number of master regulatory pathways. This ability to influence key cellular control systems, rather than binding to a single receptor or inhibiting one enzyme, explains its broad spectrum of activity across antioxidant defense, cancer biology, and inflammation.

The Nrf2 Pathway: Master Regulator of Cytoprotection

The most well-characterized mechanism of sulforaphane is its function as one of the most potent known natural inducers of the Nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway.[15] Nrf2 is a transcription factor that acts as the primary regulator of the cell's endogenous antioxidant and detoxification defense system.[25]

Under basal conditions, Nrf2 is held inactive in the cytoplasm through its binding to a repressor protein, Kelch-like ECH-associated protein 1 (Keap1).[15] As an electrophilic molecule, sulforaphane is able to react with specific cysteine residues on Keap1. This chemical modification alters Keap1's conformation, causing it to release Nrf2.[28] Once liberated, Nrf2 translocates to the cell nucleus, where it binds to a specific DNA sequence known as the Antioxidant Response Element (ARE) located in the promoter region of hundreds of genes.[27]

This binding event initiates the coordinated transcription of a vast battery of over 500 cytoprotective genes.[31] These include:

• Phase II Detoxification Enzymes: Such as Glutathione S-transferases (GSTs) and NAD(P)H:quinone oxidoreductase-1 (NQO1), which conjugate and neutralize carcinogens and other toxins, preparing them for excretion.[8]
• Antioxidant Enzymes: Such as Heme oxygenase-1 (HO-1), superoxide dismutase (SOD), and glutamate-cysteine ligase (GCL, the rate-limiting enzyme in glutathione synthesis), which collectively manage and neutralize reactive oxygen species (ROS).[28]

This mechanism distinguishes sulforaphane from direct antioxidants (like Vitamin C), which act stoichiometrically to neutralize a single free radical. Instead, sulforaphane functions as a "gene switch" or a nutrigenomic agent, catalytically amplifying the entire cellular defense network for a prolonged and powerful protective effect.[8]

Anticancer Mechanisms: Epigenetic Modulation, Apoptosis, and Cell Cycle Arrest

Sulforaphane's anticancer activity is multifaceted, intervening at all stages of carcinogenesis—initiation, promotion, and progression—through several distinct but interconnected mechanisms.[35]

• Carcinogen Detoxification: By activating the Nrf2 pathway, SFN powerfully enhances the body's ability to neutralize and eliminate potential carcinogens. This "blocking" effect prevents the initial DNA damage that can lead to cancer.[30]
• Induction of Apoptosis: In established cancer cells, SFN can trigger programmed cell death (apoptosis). It achieves this by altering the balance of pro-apoptotic (e.g., Bax) and anti-apoptotic (e.g., Bcl-2) proteins and by activating the caspase cascade, which executes the cell death program.[30] Interestingly, this can be mediated by a pro-oxidant effect specific to cancer cells; SFN can increase intracellular ROS levels, pushing already-stressed malignant cells past a threshold into apoptosis, a context-dependent action that contrasts with its antioxidant role in healthy cells.[22]
• Cell Cycle Arrest: SFN can halt the uncontrolled proliferation of cancer cells by inducing cell cycle arrest, typically at the G2/M checkpoint. This is accomplished by downregulating key cell cycle proteins like cyclin B1 and upregulating cyclin-dependent kinase inhibitors such as p21.[30]
• Epigenetic Modulation: Cancers often arise from epigenetic changes that silence tumor suppressor genes. SFN has been identified as a histone deacetylase (HDAC) inhibitor.[28] By inhibiting HDACs, SFN can help reverse this silencing, restoring the expression of critical tumor-suppressing proteins and re-establishing normal cellular control.
• Inhibition of Angiogenesis and Metastasis: For tumors to grow and spread, they must develop a new blood supply (angiogenesis). SFN has been shown to suppress key signaling pathways, such as STAT3/HIF-1$\alpha$/VEGF, thereby inhibiting angiogenesis and the potential for metastasis.[25]

Anti-inflammatory and Immunomodulatory Activity

Chronic inflammation is a well-established driver of numerous diseases, including cancer and cardiovascular disease. Sulforaphane exerts potent anti-inflammatory effects by targeting key nodes in the inflammatory cascade. It has been shown to inhibit the activation of Nuclear Factor-kappa B (NF-$\kappa$B), a master transcription factor that orchestrates the inflammatory response.[9] By inhibiting NF-$\kappa$B, SFN effectively downregulates the production of a wide array of pro-inflammatory mediators, including cytokines like tumor necrosis factor-alpha (TNF-$\alpha$), interleukin-1$\beta$ (IL-1$\beta$), and interleukin-6 (IL-6), as well as inflammatory enzymes such as cyclooxygenase-2 (COX-2).[22] This broad-spectrum anti-inflammatory action is central to its therapeutic potential in a wide range of chronic conditions.

Clinical Pharmacokinetics: A Profile of Sulforaphane in Humans

While the pharmacodynamic potency of sulforaphane is well-established, its translation into clinical efficacy is governed by its pharmacokinetics—the absorption, distribution, metabolism, and excretion (ADME) of the compound in the human body. The single greatest challenge and source of variability in sulforaphane research is its bioavailability, which can differ by more than an order of magnitude depending on the source and preparation method.

Absorption and Bioavailability: The Critical Role of Myrosinase and Host Factors

The bioavailability of sulforaphane is not intrinsic to the compound itself but is a function of its generation from its precursor, glucoraphanin. This conversion is the rate-limiting step for absorption, and its efficiency dictates systemic exposure. The bioavailability of SFN has been reported to range from less than 10% to over 80% across different studies, a variation almost entirely attributable to the presence or absence of active myrosinase enzyme.[15]

When broccoli is consumed raw or lightly steamed, or in the form of broccoli sprouts which are rich in myrosinase, the enzyme remains active. Chewing ruptures the plant cells, allowing myrosinase to rapidly hydrolyze glucoraphanin in the upper gastrointestinal tract (e.g., mouth, stomach, small intestine).[43] This leads to efficient SFN formation and rapid absorption, resulting in high bioavailability. Studies comparing raw versus cooked broccoli have shown dramatically higher absorption from raw preparations, with bioavailability being up to ten times greater.[45]

Conversely, when myrosinase is denatured by heat—as occurs with boiling, extensive steaming, or in the processing of some supplements—the intact glucoraphanin passes to the colon.[7] There, a portion of it may be hydrolyzed by myrosinase-like enzymes produced by certain species of the gut microbiota.[15] This colonic conversion is significantly slower, less efficient, and highly variable among individuals due to differences in their microbiome composition.[42] The result is delayed absorption and substantially lower overall bioavailability.[7] This fundamental difference explains why the method of preparation is a more critical determinant of the effective dose of sulforaphane than the initial glucoraphanin content of the food. Other factors, such as gastric pH and host genetics, can also influence conversion efficiency.[25]

Distribution, Metabolism, and Excretion: The Mercapturic Acid Pathway

Upon absorption into the bloodstream, the lipophilic sulforaphane is rapidly and widely distributed to tissues throughout the body, including the liver, kidneys, lungs, and prostate.[25] Its metabolism is swift and occurs primarily via the mercapturic acid pathway, a major route for detoxifying electrophilic compounds.[7]

The initial and very rapid step is conjugation with the body's primary endogenous antioxidant, glutathione (GSH), a reaction catalyzed by glutathione S-transferases (GSTs).[35] The resulting SFN-glutathione (SFN-GSH) conjugate is the main metabolite found circulating in plasma.[53] This conjugate is then sequentially broken down by enzymes into SFN-cysteine-glycine (SFN-CG), SFN-cysteine (SFN-Cys), and finally, SFN-N-acetylcysteine (SFN-NAC).[7]

These successive modifications render the molecule progressively more water-soluble, facilitating its elimination from the body. The final SFN-NAC metabolite, along with its precursors, is primarily excreted in the urine.[7] The pharmacokinetic profile is characterized by rapid absorption and elimination. Depending on the source, peak plasma concentrations of SFN and its metabolites are typically reached within 1 to 6 hours after consumption.[46] The elimination half-life is relatively short, generally reported to be between 2 and 7 hours, with the majority of an absorbed dose being excreted within 24 hours.[35] The measurement of these urinary metabolites, particularly SFN-NAC, has become the gold standard in clinical trials for quantifying bioavailability and verifying participant adherence to an intervention.[15]

Table 2: Representative Pharmacokinetic Parameters of Sulforaphane in Humans from Different Sources

Source	Tmax (Peak Time)	Bioavailability (% of Dose Excreted)	Key Observation	Reference(s)
Fresh/Raw Broccoli	1.6 h	37%	Rapid absorption, high bioavailability	46
Steamed/Cooked Broccoli	6 h	3.4% - 10.2%	Delayed absorption, very low bioavailability	46
Broccoli Sprouts (Myrosinase-active)	2-4 h	32% - 74%	Rapid absorption, very high and sustained bioavailability	7
Broccoli Powder (Myrosinase-inactive)	Delayed	19%	Delayed absorption, low bioavailability dependent on gut flora	45

Clinical Evidence and Therapeutic Potential: A Critical Review of Human Trials

The translation of sulforaphane's potent preclinical activity into tangible human health benefits is the subject of a rapidly growing body of clinical research. Trials have explored its utility across a range of conditions, from cancer prevention to metabolic disorders and detoxification. A critical review of this evidence reveals a consistent pattern: sulforaphane is more adept at modulating biomarkers of risk and physiological processes than at achieving definitive clinical cures for established diseases, with outcomes often linked to the persistent challenge of bioavailability.

Cancer Chemoprevention and Adjuvant Therapy

The strongest rationale for SFN research has been in cancer prevention. Clinical trials have yielded promising, albeit nuanced, results.

• Prostate Cancer: In men with recurrent prostate cancer, SFN has been shown to slow the rate of increase of prostate-specific antigen (PSA), a key marker of disease progression.[55] A year-long dietary intervention study (NCT01950143) is currently investigating whether a broccoli-rich diet can favorably alter gene expression and metabolite profiles in the prostate tissue of men under active surveillance, aiming to intercept cancer development.[57]
• Breast Cancer: While preclinical studies show SFN potently inhibits breast cancer stem cells by targeting the Wnt/$\beta$-catenin pathway, clinical applications are still emerging.[36] A notable trial (NCT03934905) is evaluating SFN's potential as an adjuvant therapy to protect against the cardiotoxicity of the common chemotherapy drug doxorubicin in breast cancer patients.[58]
• Lung Cancer: A randomized Phase II trial in former smokers at high risk for lung cancer found that 12 months of SFN supplementation did not alter bronchial histopathology but did significantly reduce the cellular proliferation marker Ki-67.[59] This effect was more pronounced in individuals who demonstrated higher SFN bioavailability, directly linking pharmacokinetic exposure to a pharmacodynamic response.[59]
• Melanoma: A planned trial (NCT07040280) aims to determine if SFN can prevent melanoma in high-risk individuals by monitoring its effect on the progression of atypical moles.[60]

The collective evidence suggests SFN's primary role in oncology may be in chemoprevention—reducing the risk of cancer initiation or progression—and as a supportive agent to mitigate the side effects of conventional treatments.

Management of Inflammatory and Metabolic Conditions

Given its potent anti-inflammatory and Nrf2-activating properties, SFN has been investigated for a variety of chronic inflammatory and metabolic diseases.

• Systemic Inflammation: In a 10-week study involving overweight subjects, daily consumption of broccoli sprouts led to a significant decrease in the systemic inflammatory markers interleukin-6 (IL-6) and C-reactive protein.[61] The PRO SANI trial (NCT05146804) is further exploring SFN's effect on inflammatory biomarkers in healthy individuals subjected to a high-calorie challenge designed to induce a transient inflammatory state.[62]
• Liver Health: A two-month, randomized, placebo-controlled trial in Japanese men demonstrated that broccoli sprout extract significantly improved markers of liver function (ALT and $\gamma$-GTP) and concurrently reduced urinary 8-hydroxydeoxyguanosine, a marker of systemic oxidative stress.[63]
• Metabolic Disorders: Studies have indicated that SFN can improve glycemic control in patients with type 2 diabetes.[64] In the context of inflammatory bowel disease, a pilot study is underway to assess whether broccoli sprouts can reduce inflammatory markers in patients with mild ulcerative colitis.[65]

Environmental Toxin Detoxification

One of the most compelling demonstrations of SFN's clinical efficacy comes from a trial focused on detoxification. A 12-week randomized, placebo-controlled trial was conducted in a region of China with high levels of air pollution.[66] Participants consuming a broccoli sprout beverage showed a rapid and sustained increase in the urinary excretion of the metabolites of known airborne carcinogens. Specifically, the excretion of benzene metabolites increased by 61% and acrolein metabolites by 23% compared to the placebo group.[66] This study provides powerful in-human evidence that SFN, via its Nrf2-mediated induction of Phase II enzymes, can tangibly enhance the detoxification of environmental pollutants.

Emerging Therapeutic Areas and Limitations of Current Evidence

The scope of SFN research continues to expand into new areas, including autism spectrum disorder (where it has shown some symptomatic improvement), asthma, and neurodegenerative diseases.[55] A pilot trial (CO-Sprout) is even assessing its safety and feasibility for mitigating symptoms in pregnant women with COVID-19, leveraging its anti-inflammatory and anti-viral potential.[68]

However, the overall body of evidence remains nascent. A comprehensive review of 84 clinical trials highlighted significant limitations, including small sample sizes and inconsistent outcomes.[64] Critically, approximately half of all completed trials remain unpublished, raising a strong possibility of publication bias, where studies with negative or null results are less likely to be reported.[64] This underscores the need for larger, more robustly designed, and transparently reported trials to confirm the promising signals seen in many pilot studies.

Table 3: Summary of Key Clinical Trials of Sulforaphane/Broccoli Extracts

Trial ID / Study	Condition/Indication	Study Design	Intervention	Key Outcomes
NCT01950143	Prostate Cancer Prevention	Randomized, double-blind	Weekly broccoli soup with varying glucoraphanin levels for 1 year	Changes in prostate tissue gene expression and metabolite levels 57
NCT03232138	Lung Cancer Prevention (Former Smokers)	Randomized, placebo-controlled	95 µmol sulforaphane daily for 12 months	No change in histopathology; significant reduction in Ki-67 proliferation index 59
NCT03934905	Breast Cancer (Adjuvant)	Randomized, placebo-controlled	Sulforaphane or placebo during doxorubicin chemotherapy	Assess safety and cardioprotective effects (prevention of DOX-induced cardiotoxicity) 58
NCT07040280	Melanoma Prevention	Randomized, placebo-controlled	Sulforaphane or placebo for 12 months	Effect on changes in atypical moles over time 60
NCT03390855	Inflammation (Overweight Subjects)	Controlled intervention study	30 g/day broccoli sprouts for 10 weeks	Significant decrease in inflammatory markers IL-6 and C-reactive protein 61
Kikuchi et al. (2015)	Liver Function	Randomized, placebo-controlled, double-blind	Broccoli sprout extract (30 mg glucoraphanin) daily for 2 months	Significant decrease in liver enzymes (ALT, $\gamma$-GTP) and oxidative stress marker (8-OHdG) 63
Egner et al. (2014)	Detoxification (Air Pollution)	Randomized, placebo-controlled	Broccoli sprout beverage daily for 12 weeks	Rapid and sustained increase in excretion of benzene (61%) and acrolein (23%) metabolites 66
U of Michigan	Ulcerative Colitis	Non-placebo, 2-arm trial	1 or 3 servings of broccoli sprouts daily for 4 weeks	Assess changes in sulforaphane levels and inflammatory markers 65
CO-Sprout Trial	COVID-19 in Pregnancy	Pilot, randomized, placebo-controlled	42 mg sulforaphane daily for 14 days	Assess feasibility, safety, and effect on symptom duration and inflammatory biomarkers 68

Commercialization and Regulatory Oversight of Broccoli-Derived Supplements

The translation of scientific research on sulforaphane into consumer products has led to a growing market for broccoli-derived dietary supplements. The formulation of these products and the claims they can legally make are shaped by both the scientific understanding of sulforaphane's biochemistry and the complex global regulatory landscape for nutraceuticals.

The Nutraceutical Market: A Survey of Commercial Formulations

The commercial supplement market features a range of products designed to deliver a bioactive dose of sulforaphane, typically derived from broccoli seeds or sprouts, which are the most concentrated sources of its precursor, glucoraphanin.[69] The most scientifically sophisticated of these products are formulated as "sulforaphane production systems," directly addressing the bioavailability challenge posed by the instability of the myrosinase enzyme.

• Avmacol®: This brand is notable for its use in numerous human clinical trials. Its formulation includes both glucoraphanin from broccoli extract and a stabilized, active myrosinase enzyme trademarked as Myrosimax®. This two-component system is designed to ensure the reliable conversion of glucoraphanin to sulforaphane upon ingestion.[71]
• SulforaClear™: Similarly, this product features a complex called Brassinase™, which combines glucoraphanin with an active myrosinase enzyme to support sulforaphane production.[73]
• Broc Shot: This product takes a different approach, providing a powder of broccoli seed and horseradish root (another source of myrosinase) that is activated in water just before consumption. The company guarantees a specific yield of 12 mg of active sulforaphane per serving and emphasizes its rigorous third-party testing for potency and purity from contaminants like pesticides and heavy metals.[74]

The formulation strategies of these leading brands reflect a mature understanding of the core scientific principle: delivering glucoraphanin alone is insufficient. Ensuring a reliable dose of sulforaphane requires the co-delivery of an active myrosinase enzyme.

Navigating the Global Regulatory Landscape (FDA, TGA, EMA)

The marketing and sale of broccoli-derived supplements are governed by distinct regulatory frameworks in different regions, which primarily classify them as foods or supplements, not as drugs. This classification has profound implications for the types of health claims that can be made.

• United States (FDA): In the U.S., these products are regulated as dietary supplements under the Dietary Supplement Health and Education Act (DSHEA). This framework requires that products are safe for consumption but does not require pre-market approval of efficacy. Crucially, supplements cannot be marketed with claims to "diagnose, treat, cure, or prevent any disease," as such claims would define the product as an unapproved "new drug".[75] The FDA actively enforces this distinction, as evidenced by a warning letter issued to Natural Sprout Co. LLC for making explicit anti-cancer claims (e.g., "believed to inhibit tumor growth") for its broccoli sprout powder. The FDA stated that these claims established the product as a drug, and its sale was therefore in violation of the Federal Food, Drug, and Cosmetic Act.[75]
• Australia (TGA): The Therapeutic Goods Administration (TGA) employs a risk-based tiered system for complementary medicines. A broccoli sprout extract making general health claims (e.g., "supports antioxidant defenses") would likely be "Listed" (AUST L), requiring evidence of safety and quality but not efficacy. If it were to make a higher-level claim based on scientific evidence, it could potentially be "Assessed Listed" (AUST L(A)), which requires an efficacy review.[76]
• European Union (EMA): The European Medicines Agency provides pathways for herbal medicinal products. A product with a long history of use (30 years) could seek a "Traditional Use Registration" without clinical trial data. A product with at least 10 years of "Well-established Use" supported by scientific literature could seek a marketing authorization based on that evidence.[77] A novel extract or formulation without such a history would likely require a full "Stand-alone application" with company-sponsored clinical data, a much more rigorous and costly process akin to drug approval.[77]

This regulatory environment creates a significant disconnect between the therapeutic potential being actively investigated in clinical trials and the marketing language legally permitted for consumer-facing products. While a clinical trial may study sulforaphane for "prostate cancer prevention," a supplement containing the same ingredient can only make vague "structure/function" claims, such as "supports cellular health."

Table 4: Comparison of Representative Commercial Sulforaphane Supplements

Product Name	Key Ingredients	Guaranteed Yield / Potential	Dosage Form	Key Features
Avmacol® Extra Strength	Glucoraphanin (broccoli extract), Myrosinase (Myrosimax®), Maitake mushroom extract	Sulforaphane production system; amount not specified	Tablet	Two-component system with active enzyme; used in multiple clinical trials 71
SulforaClear™	Glucoraphanin (broccoli seed/sprout), Myrosinase (Brassinase™)	1 mg sulforaphane potential from 12 mg total glucoraphanin per 2 capsules	Capsule	Two-component system with standardized glucoraphanin and active enzyme 73
Broc Shot	Broccoli Seed Powder, Horseradish Root Powder	12 mg active sulforaphane per serving	Powder (activated in water)	Delivers pre-activated SFN; third-party tested for purity and potency 74

Synthesis, Insights, and Future Directions

The analysis of broccoli in a pharmacological context reveals a subject of profound complexity and immense potential. It is a story of dual identities, biochemical paradoxes, and a widening gap between scientific discovery and public communication. While the allergenic extract DB10511 represents a niche diagnostic tool, the vegetable itself is a source of sulforaphane, a phytochemical with a compelling, multi-modal mechanism of action that positions it as a promising agent for disease prevention and supportive therapy.

The central scientific narrative is the stability-activity paradox of the glucoraphanin-sulforaphane system. The therapeutic efficacy of any broccoli-derived intervention is not a function of its glucoraphanin content alone, but of its ability to facilitate the conversion of this stable pro-drug into the active, unstable sulforaphane. This conversion, mediated by the heat-labile myrosinase enzyme, is the master variable controlling bioavailability. The failure to account for this variable is a likely contributor to the inconsistent outcomes seen across the landscape of clinical research. The evidence strongly suggests that sulforaphane's primary clinical strength lies in its ability to modulate underlying pathophysiology—enhancing detoxification, reducing inflammation, and slowing cellular proliferation—rather than acting as a curative agent for advanced disease.

Key Insights and Recommendations for Research and Development

Based on this comprehensive review, the following recommendations are proposed to advance the field:

• For Clinical Research:

1. Standardize Interventions: Future clinical trials must move away from poorly characterized extracts or dietary advice. Interventions should utilize standardized, myrosinase-active formulations that have a confirmed and reproducible yield of sulforaphane.
2. Measure Bioavailability: Pharmacokinetic analysis, at a minimum through the measurement of urinary sulforaphane metabolites, should be incorporated into all human trials. This will allow participants to be stratified by exposure level (e.g., "low vs. high absorbers"), enabling a more accurate assessment of the compound's true dose-response relationship and efficacy.
3. Focus on Prevention and Adjuvant Settings: Research efforts should be prioritized in chemoprevention, risk reduction, and adjuvant therapy settings, where sulforaphane's mechanism of enhancing endogenous resilience is most likely to show a clinical benefit. The use of validated biomarkers as primary endpoints in these studies is a robust strategy.

• For Product Development:

1. Optimize Bioavailability: The primary goal of formulation science in this area should be to maximize the consistent conversion of glucoraphanin to sulforaphane. This includes improving the stability of the myrosinase enzyme, exploring enteric coating to protect the enzyme from gastric acid, or developing methods to stabilize the active sulforaphane molecule itself.
2. Explore the Microbiome: Given the role of gut bacteria in converting glucoraphanin in the absence of plant myrosinase, research into synbiotic formulations—combining glucoraphanin with specific probiotic strains known to possess myrosinase-like activity—could open a new avenue for enhancing bioavailability.

• For Regulatory Science: The significant disconnect between the robust scientific investigation of sulforaphane for specific diseases and the restrictive claims allowed for dietary supplements hinders public health communication. A modernized regulatory pathway is needed for well-researched nutraceuticals that would allow for qualified, evidence-based health claims. This would enable consumers and healthcare professionals to make more informed decisions based on the totality of scientific evidence.

Concluding Remarks

In conclusion, the journey of broccoli from a common vegetable to a subject of serious pharmacological inquiry is a testament to the power of phytochemicals in human health. Sulforaphane stands out as a nutrigenomic agent of remarkable potency and breadth. Its ability to activate the Nrf2 master regulatory switch provides a powerful, upstream mechanism for bolstering cellular defense against a wide range of stressors, from environmental carcinogens to chronic inflammation. However, realizing this immense therapeutic promise on a consistent and predictable basis requires a concerted effort to overcome the fundamental pharmacokinetic challenge of bioavailability. Through rigorous formulation science, well-designed clinical trials, and a more nuanced regulatory approach, sulforaphane derived from broccoli has the potential to transition from a promising phytochemical into a cornerstone of evidence-based preventive medicine.

Works cited

1. Broccoli: Uses, Interactions, Mechanism of Action | DrugBank Online, accessed October 24, 2025, https://go.drugbank.com/drugs/DB10511
2. Advanced Filter - DrugBank, accessed October 24, 2025, https://go.drugbank.com/unearth/q?searcher=drugs&utf8=%E2%9C%93&query=BROCCOLI+AND+CABBAGE+AND+CARROT+AND+CAULIFLOWER+AND+TURNIP&search_type=drugs&button=
3. Brassica oleracea var italica and Their By-Products as Source of Bioactive Compounds and Food Applications in Bakery Products - MDPI, accessed October 24, 2025, https://www.mdpi.com/2304-8158/13/21/3513
4. Broccoli (Brassica Oleracea var. Italica): Potential candidate in the health management - Scholars Research Library, accessed October 24, 2025, https://www.scholarsresearchlibrary.com/articles/broccoli-brassica-oleracea-var-italica-potential-candidate-in-the-healthmanagement.pdf
5. Brassica oleracea var italica and Their By-Products as Source of Bioactive Compounds and Food Applications in Bakery Products - PubMed, accessed October 24, 2025, https://pubmed.ncbi.nlm.nih.gov/39517297/
6. Identification of Distinctive Primary Metabolites Influencing Broccoli (Brassica oleracea, var. Italica) Taste - MDPI, accessed October 24, 2025, https://www.mdpi.com/2304-8158/12/2/339
7. Disposition of Glucosinolates and Sulforaphane in Humans After Ingestion of Steamed and Fresh Broccoli - ResearchGate, accessed October 24, 2025, https://www.researchgate.net/publication/11819566_Disposition_of_Glucosinolates_and_Sulforaphane_in_Humans_After_Ingestion_of_Steamed_and_Fresh_Broccoli
8. Sulforaphane Glucosinolate Monograph - Alternative Medicine Review, accessed October 24, 2025, https://altmedrev.com/wp-content/uploads/2019/02/v15-4-352.pdf
9. Glucosinolates From Cruciferous Vegetables and Their ... - Frontiers, accessed October 24, 2025, https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.767975/full
10. Human, Animal and Plant Health Benefits of Glucosinolates and Strategies for Enhanced Bioactivity: A Systematic Review - NIH, accessed October 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7464879/
11. Glucosinolate - Wikipedia, accessed October 24, 2025, https://en.wikipedia.org/wiki/Glucosinolate
12. Glucosinolates in Human Health: Metabolic Pathways, Bioavailability, and Potential in Chronic Disease Prevention - MDPI, accessed October 24, 2025, https://www.mdpi.com/2304-8158/14/6/912
13. (PDF) Variation of sulforaphane levels in broccoli (Brassica oleracea var. italica) during flower development and the role of gene AOP2 - ResearchGate, accessed October 24, 2025, https://www.researchgate.net/publication/262860043_Variation_of_sulforaphane_levels_in_broccoli_Brassica_oleracea_var_italica_during_flower_development_and_the_role_of_gene_AOP2
14. Glucoraphanin: Uses, Interactions, Mechanism of Action | DrugBank Online, accessed October 24, 2025, https://go.drugbank.com/drugs/DB15436
15. Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase | PLOS One - Research journals, accessed October 24, 2025, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140963
16. Glucosinolates: Bioavailability and Importance to Health - IMR Press, accessed October 24, 2025, https://article.imrpress.com/journal/IJVNR/72/1/10.1024/0300-9831.72.1.26/05fe8f36e5bbc3d2c39e18d5af99d902.pdf
17. Glucoraphanin conversion into sulforaphane and related compounds by gut microbiota - Frontiers, accessed October 24, 2025, https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2025.1497566/full
18. Glucosinolates: Natural Occurrence, Biosynthesis, Accessibility, Isolation, Structures, and Biological Activities - MDPI, accessed October 24, 2025, https://www.mdpi.com/1420-3049/25/19/4537
19. Glucoraphanin | C12H23NO10S3 | CID 9548634 - PubChem, accessed October 24, 2025, https://pubchem.ncbi.nlm.nih.gov/compound/Glucoraphanin
20. Definition of sulforaphane - NCI Drug Dictionary - National Cancer Institute, accessed October 24, 2025, https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane
21. Sulforaphane - Wikipedia, accessed October 24, 2025, https://en.wikipedia.org/wiki/Sulforaphane
22. Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane, accessed October 24, 2025, https://www.mdpi.com/2227-9059/12/6/1169
23. Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality? - PMC - NIH, accessed October 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4736808/
24. Study on degradation kinetics of sulforaphane in broccoli extract - ResearchGate, accessed October 24, 2025, https://www.researchgate.net/publication/260212265_Study_on_degradation_kinetics_of_sulforaphane_in_broccoli_extract
25. Therapeutic potential of sulforaphane in liver diseases: a review - Frontiers, accessed October 24, 2025, https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1256029/full
26. pmc.ncbi.nlm.nih.gov, accessed October 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4736808/#:~:text=Sulforaphane%20is%20a%20potent%20Nrf2,%2D2B%20cells%20%5B71%5D.
27. Eat Your Broccoli: Oxidative Stress, NRF2, and Sulforaphane in Chronic Kidney Disease, accessed October 24, 2025, https://www.mdpi.com/2072-6643/13/1/266
28. L-Sulforaphane: mechanism of action and clinical applications - ChemicalBook, accessed October 24, 2025, https://www.chemicalbook.com/article/l-sulforaphane-mechanism-of-action-and-clinical-applications.htm
29. Activation of the Nrf2 Pathway by Sulforaphane Improves Hypoglycaemia-Induced Cognitive Impairment in a Rodent Model of Type 1 Diabetes - MDPI, accessed October 24, 2025, https://www.mdpi.com/2076-3921/14/3/308
30. Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms ..., accessed October 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6011061/
31. Sulforaphane: Its “Coming of Age” as a Clinically Relevant Nutraceutical in the Prevention and Treatment of Chronic Disease - PubMed Central, accessed October 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6815645/
32. Sulforaphane, in Addressing Cancer Initiation and Progression, accessed October 24, 2025, https://www.learntobeatcancer.org/sulforaphane-in-addressing-cancer-initiation-and-progression
33. Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice - PMC - PubMed Central, accessed October 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4713291/
34. Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation - ResearchGate, accessed October 24, 2025, https://www.researchgate.net/publication/283965972_Sulforaphane_Protects_against_Cardiovascular_Disease_via_Nrf2_Activation
35. Sulforaphane as a Promising Natural Molecule for Cancer Prevention and Treatment, accessed October 24, 2025, https://www.researchgate.net/publication/351002105_Sulforaphane_as_a_Promising_Natural_Molecule_for_Cancer_Prevention_and_Treatment
36. Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts ..., accessed October 24, 2025, https://aacrjournals.org/clincancerres/article/16/9/2580/76213/Sulforaphane-a-Dietary-Component-of-Broccoli
37. Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract - PMC - NIH, accessed October 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4394840/
38. Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancreatic cancer cells - Frontiers, accessed October 24, 2025, https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1442737/full
39. Anti-inflammatory properties of broccoli sprout extract in a lipopolysaccharide-induced testicular dysfunction - Journal of Animal Reproduction and Biotechnology, accessed October 24, 2025, https://www.e-jarb.org/journal/view.html?uid=2649&vmd=Full
40. Comparison of Pharmacokinetics and Anti-Pulmonary Fibrosis-Related Effects of Sulforaphane and Sulforaphane N-acetylcysteine - MDPI, accessed October 24, 2025, https://www.mdpi.com/1999-4923/13/7/958
41. Absolute bioavailability and dose-dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in rat | British Journal of Nutrition - Cambridge University Press & Assessment, accessed October 24, 2025, https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/absolute-bioavailability-and-dosedependent-pharmacokinetic-behaviour-of-dietary-doses-of-the-chemopreventive-isothiocyanate-sulforaphane-in-rat/51DBBECCE21B5C98B9D2EB42C613FD0D
42. Bioavailability of Sulforaphane Following Ingestion of Glucoraphanin-Rich Broccoli Sprout and Seed Extracts with Active Myrosinase: A Pilot Study of the Effects of Proton Pump Inhibitor Administration - NIH, accessed October 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6682992/
43. A Physiological-Based Model for Simulating the Bioavailability and Kinetics of Sulforaphane from Broccoli Products - MDPI, accessed October 24, 2025, https://www.mdpi.com/2304-8158/10/11/2761
44. Bioavailability of Glucosinolates and Their Breakdown Products: Impact of Processing, accessed October 24, 2025, https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2016.00024/full
45. Sulforaphane Absorption and Excretion Following Ingestion of a Semi-Purified Broccoli Powder Rich in Glucoraphanin and Broccoli Sprouts in Healthy Men | Request PDF - ResearchGate, accessed October 24, 2025, https://www.researchgate.net/publication/49760986_Sulforaphane_Absorption_and_Excretion_Following_Ingestion_of_a_Semi-Purified_Broccoli_Powder_Rich_in_Glucoraphanin_and_Broccoli_Sprouts_in_Healthy_Men
46. Bioavailability and Kinetics of Sulforaphane in Humans after Consumption of Cooked versus Raw Broccoli | Journal of Agricultural and Food Chemistry - ACS Publications, accessed October 24, 2025, https://pubs.acs.org/doi/abs/10.1021/jf801989e
47. Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli - PubMed, accessed October 24, 2025, https://pubmed.ncbi.nlm.nih.gov/11525594/
48. Bioavailability of Glucosinolates and Their Breakdown Products: Impact of Processing, accessed October 24, 2025, https://www.researchgate.net/publication/305476330_Bioavailability_of_Glucosinolates_and_Their_Breakdown_Products_Impact_of_Processing
49. Metabolism of Sulforaphane in Humans: Supplements vs. Whole Foods - ResearchGate, accessed October 24, 2025, https://www.researchgate.net/publication/352634029_Metabolism_of_Sulforaphane_in_Humans_Supplements_vs_Whole_Foods
50. Bioavailability of Sulforaphane from Two Broccoli Sprout Beverages: Results of a Short-term, Cross-over Clinical Trial in Qidong, China | Cancer Prevention Research - AACR Journals, accessed October 24, 2025, https://aacrjournals.org/cancerpreventionresearch/article/4/3/384/49770/Bioavailability-of-Sulforaphane-from-Two-Broccoli
51. Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice, accessed October 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3253624/
52. Pharmacokinetics and Pharmacodynamics of Phase II Drug Metabolizing/Antioxidant Enzymes Gene Response by Anti-cancer Agent Sulforaphane in Rat Lymphocytes - PMC - PubMed Central, accessed October 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3580178/
53. Measuring Sulforaphane and Its Metabolites in Human Plasma: A High Throughput Method, accessed October 24, 2025, https://www.researchgate.net/publication/339386270_Measuring_Sulforaphane_and_Its_Metabolites_in_Human_Plasma_A_High_Throughput_Method
54. Measuring Sulforaphane and Its Metabolites in Human Plasma: A High Throughput Method, accessed October 24, 2025, https://www.mdpi.com/1420-3049/25/4/829
55. SULFORAPHANE: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews - WebMD, accessed October 24, 2025, http://www.webmd.com/vitamins/ai/ingredientmono-1070/sulforaphane
56. A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer - PMC - PubMed Central, accessed October 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4390425/
57. Study Details | NCT01950143 | Effect of Sulforaphane on Prostate ..., accessed October 24, 2025, https://clinicaltrials.gov/study/NCT01950143
58. Study Details | NCT03934905 | Protective Effects of the Nutritional ..., accessed October 24, 2025, https://clinicaltrials.gov/study/NCT03934905
59. Randomized Phase II Clinical Trial of Sulforaphane in Former ..., accessed October 24, 2025, https://pubmed.ncbi.nlm.nih.gov/40041932/
60. Testing the Effect of Sulforaphane, a Compound Naturally Found in ..., accessed October 24, 2025, https://prevention.cancer.gov/clinical-trials/clinical-trials-search/nct07040280
61. Effects of long-term consumption of broccoli sprouts on inflammatory ..., accessed October 24, 2025, https://pubmed.ncbi.nlm.nih.gov/29573889/
62. Study Details | NCT05146804 | The PROtective Effect of ..., accessed October 24, 2025, https://clinicaltrials.gov/study/NCT05146804
63. Sulforaphane-rich broccoli sprout extract improves hepatic ..., accessed October 24, 2025, https://www.wjgnet.com/1007-9327/full/v21/i43/12457.htm
64. Sulforaphane as a potential therapeutic agent: a comprehensive ..., accessed October 24, 2025, https://www.cambridge.org/core/product/D7C218557A23D9942DAE16AE7C193B4B
65. Broccoli Sprouts for Ulcerative Colitis · Recruiting Participants for ..., accessed October 24, 2025, https://www.withpower.com/trial/phase-colitis-8-2022-9e1d0
66. Rapid and Sustainable Detoxication of Airborne Pollutants by ..., accessed October 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4125483/
67. Sulforaphane: Benefits, Uses, Side Effects, and More - Health, accessed October 24, 2025, https://www.health.com/sulforaphane-benefits-8658448
68. CO-Sprout—A Pilot Double-Blinded Placebo-Controlled ... - MDPI, accessed October 24, 2025, https://www.mdpi.com/2072-6643/15/18/3980
69. The Challenges of Designing and Implementing Clinical Trials With Broccoli Sprouts… and Turning Evidence Into Public Health Action - Frontiers, accessed October 24, 2025, https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2021.648788/full
70. Sulforaphane - Walmart, accessed October 24, 2025, https://www.walmart.com/c/kp/sulforaphane
71. Best Sulforaphane Supplement | Buy Avmacol® Extra Strength - 75 ..., accessed October 24, 2025, https://www.avmacol.com/products/avmacol-extra-strength
72. Avmacol® Regular Strength - Default Title, accessed October 24, 2025, https://www.avmacol.com/products/avmacol-regular-strength/1000
73. SulforaClear™ - Broccoli Sulforaphane Supplement | Metagenics, accessed October 24, 2025, https://www.metagenics.com/en-us/product/sulforaclear
74. Sulforaphane Supplement | Natural & Organic - Broc Shot, accessed October 24, 2025, https://brocshot.com/collections/sulforaphane-supplement
75. Natural Sprout Co. LLC - 610151 - 10/29/2020 | FDA, accessed October 24, 2025, https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/natural-sprout-co-llc-610151-10292020
76. Regulation of Medicines | Complementary Therapies | %, accessed October 24, 2025, https://www.cancercouncil.com.au/cancer-information/living-well/complementary-therapies/safety-concerns/regulation-of-medicines/
77. Herbal medicinal products | European Medicines Agency (EMA), accessed October 24, 2025, https://www.ema.europa.eu/en/human-regulatory-overview/herbal-medicinal-products